These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1237 related articles for article (PubMed ID: 1517373)

  • 41. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Arlt W; Bancos I; Dralle H; Newell-Price J; Sahdev A; Tabarin A; Terzolo M; Tsagarakis S; Dekkers OM
    Eur J Endocrinol; 2016 Aug; 175(2):G1-G34. PubMed ID: 27390021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical Cushing's syndrome resulting from black adrenal adenoma. A case report.
    Tokunagaa H; Miyamura N; Sasaki K; Yoshizato K; Itasaka M; Nakamaru K; Suefuji M; Kawashima J; Matsumoto K; Sasano H; Araki E
    Horm Res; 2004; 62(2):60-6. PubMed ID: 15211088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
    Findling JW; Raff H; Aron DC
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes.
    Midorikawa S; Sanada H; Hashimoto S; Suzuki T; Watanabe T; Sasano H
    Endocr J; 2001 Apr; 48(2):167-74. PubMed ID: 11456263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A case of Cushing's syndrome due to bilateral multiple adrenal adenomas].
    Ashida S; Kataoka S; Yamasaki I; Yamashita M; Ohashi Y; Morioka M; Shuin T
    Hinyokika Kiyo; 1997 Aug; 43(8):567-70. PubMed ID: 9310779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
    Kołomecki K; Stepień H; Bartos M; Narebski J
    Neoplasma; 2001; 48(2):116-21. PubMed ID: 11478691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
    Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
    Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.
    Nunes ML; Vattaut S; Corcuff JB; Rault A; Loiseau H; Gatta B; Valli N; Letenneur L; Tabarin A
    J Clin Endocrinol Metab; 2009 Feb; 94(2):456-62. PubMed ID: 19001518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different patterns of steroid secretion in patients with adrenal incidentaloma.
    Terzolo M; Osella G; Alì A; Borretta G; Magro GP; Termine A; Paccotti P; Angeli A
    J Clin Endocrinol Metab; 1996 Feb; 81(2):740-4. PubMed ID: 8636297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing's syndrome.
    Brossaud J; Charret L; De Angeli D; Haissaguerre M; Ferriere A; Puerto M; Gatta-Cherifi B; Corcuff JB; Tabarin A
    Eur J Endocrinol; 2021 Mar; 184(3):445-454. PubMed ID: 33449913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications.
    Vassilatou E; Vryonidou A; Ioannidis D; Paschou SA; Panagou M; Tzavara I
    Eur J Endocrinol; 2014 Jul; 171(1):37-45. PubMed ID: 24743396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preclinical Cushing's syndrome: report of seven cases and a review of the literature.
    Morioka M; Fujii T; Matsuki T; Jo Y; Kobayashi T; Tanaka H; Ohashi T; Kondo K
    Int J Urol; 2000 Apr; 7(4):126-32. PubMed ID: 10810968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical Evaluation of Primary Aldosteronism with Subclinical Cushing's Syndrome].
    Furuta N; Naruoka T; Igarashi T; Bando S; Yamada H; Kimura T; Egawa S
    Hinyokika Kiyo; 2015 May; 61(5):185-90. PubMed ID: 26087819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
    Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Forty-one cases of Cushing's syndrome: a comparison between Cushing's syndrome (adrenal adenoma) and Cushing's disease (adrenal hyperplasia)].
    Komiya I; Takasu N; Ohara N; Nagasawa Y; Ohtsuka H; Asawa T; Yamada T
    Nihon Naibunpi Gakkai Zasshi; 1992 Jun; 68(6):607-22. PubMed ID: 1633931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An adolescent with food-dependent Cushing's syndrome secondary to ectopic expression of GIP receptor in unilateral adrenal adenoma.
    Noordam C; Hermus AR; Pesman G; N'Diaye N; Sweep CG; Lacroix A; Otten BJ
    J Pediatr Endocrinol Metab; 2002 Jun; 15(6):853-60. PubMed ID: 12099397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.